Literature DB >> 14600023

Pin1 modulates the structure and function of human RNA polymerase II.

Yu-Xin Xu1, Yutaka Hirose, Xiao Zhen Zhou, Kun Ping Lu, James L Manley.   

Abstract

The C-terminal domain of the RNA polymerase (RNAP) II largest subunit (CTD) plays critical roles both in transcription of mRNA precursors and in the processing reactions needed to form mature mRNAs. The CTD undergoes dynamic changes in phosphorylation during the transcription cycle, and this plays a significant role in coordinating its multiple activities. But how these changes themselves are regulated is not well understood. Here we show that the peptidyl-prolyl isomerase Pin1 influences the phosphorylation status of the CTD in vitro by inhibiting the CTD phosphatase FCP1 and stimulating CTD phosphorylation by cdc2/cyclin B. This is reflected in vivo by accumulation of hypophosphorylated RNAP II in pin1-/- cells, and of a novel hyper-hyperphosphorylated form in cells induced to overexpress Pin1. This hyper-hyperphosphorylated form of RNAP II also accumulates in M-phase cells, in a Pin1-dependent manner, and associates specifically with Pin1. Functionally, we find that Pin1 overexpression specifically inhibits ongoing transcription of mRNA precursors in vivo and both transcription and RNAP II-stimulated pre-mRNA splicing in cell extracts. Pin1 thus plays a significant role in regulating RNAP II CTD structure and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600023      PMCID: PMC280625          DOI: 10.1101/gad.1135503

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

1.  A protein phosphatase functions to recycle RNA polymerase II.

Authors:  H Cho; T K Kim; H Mancebo; W S Lane; O Flores; D Reinberg
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 3.  RNA polymerase II and the integration of nuclear events.

Authors:  Y Hirose; J L Manley
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

4.  Transcription-independent phosphorylation of the RNA polymerase II C-terminal domain (CTD) involves ERK kinases (MEK1/2).

Authors:  F Bonnet; M Vigneron; O Bensaude; M F Dubois
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

5.  Dynamic association of capping enzymes with transcribing RNA polymerase II.

Authors:  S C Schroeder; B Schwer; S Shuman; D Bentley
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

6.  Structural basis for phosphoserine-proline recognition by group IV WW domains.

Authors:  M A Verdecia; M E Bowman; K P Lu; T Hunter; J P Noel
Journal:  Nat Struct Biol       Date:  2000-08

7.  Stem-loop binding protein, the protein that binds the 3' end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms.

Authors:  M L Whitfield; L X Zheng; A Baldwin; T Ohta; M M Hurt; W F Marzluff
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery.

Authors:  X Wu; C B Wilcox; G Devasahayam; R L Hackett; M Arévalo-Rodríguez; M E Cardenas; J Heitman; S D Hanes
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

Review 9.  Mediator of transcriptional regulation.

Authors:  L C Myers; R D Kornberg
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1.

Authors:  A Albert; S Lavoie; M Vincent
Journal:  J Cell Sci       Date:  1999-08       Impact factor: 5.285

View more
  67 in total

Review 1.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

Review 2.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

3.  Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle.

Authors:  Zhuo Ma; David Atencio; Cassandra Barnes; Holland DeFiglio; Steven D Hanes
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

4.  Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II.

Authors:  Christina Ohrmalm; Göran Akusjärvi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 6.  Control of alternative pre-mRNA splicing by Ca(++) signals.

Authors:  Jiuyong Xie
Journal:  Biochim Biophys Acta       Date:  2008-01-17

7.  Pin1 modulates RNA polymerase II activity during the transcription cycle.

Authors:  Yu-Xin Xu; James L Manley
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

8.  SysPTM: a systematic resource for proteomic research on post-translational modifications.

Authors:  Hong Li; Xiaobin Xing; Guohui Ding; Qingrun Li; Chuan Wang; Lu Xie; Rong Zeng; Yixue Li
Journal:  Mol Cell Proteomics       Date:  2009-04-14       Impact factor: 5.911

Review 9.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

10.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.